<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27821089</article-id>
      <article-id pub-id-type="pmc">5100286</article-id>
      <article-id pub-id-type="publisher-id">737</article-id>
      <article-id pub-id-type="doi">10.1186/s12883-016-0737-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Posterior reversible encephalopathy as the first manifestation of Bickerstaff&#x2019;s brainstem encephalitis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Pei-Ru</given-names>
          </name>
          <address>
            <email>bgbkbear1986@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3492-9902</contrib-id>
          <name>
            <surname>Chen</surname>
            <given-names>Shih-Pin</given-names>
          </name>
          <address>
            <phone>886-2- 28712121</phone>
            <email>chensp1977@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, 112 Taiwan </aff>
        <aff id="Aff2"><label>2</label>Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan </aff>
        <aff id="Aff3"><label>3</label>Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>215</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>11</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Posterior reversible encephalopathy syndrome (PRES) has been associated with Guillain-Barre syndrome in rare cases. Here we report a patient in whom PRES was the presenting manifestation of Bickerstaff&#x2019;s brainstem encephalitis.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 75-year-old woman presented with acute onset of hypertension, headache, blurred vision, and left eyelid drooping. Magnetic resonance imaging of the brain showed characteristic PRES lesions involving the parietal and occipital lobes bilaterally. On the 6th day after symptom onset, the patient developed complete ptosis and external ophthalmoplegia of both eyes, progressive ataxia, and bilateral lower limb weakness. Cerebrospinal fluid analyses revealed albuminocytological dissociation (protein: 66.6&#xA0;mg/dL, WBC: 0/&#x3BC;l), and nerve conduction studies showed demyelinating sensorimotor polyneuropathy. The patient developed somnolence and a left extensor plantar response on the 8th day. A diagnosis of Bickerstaff&#x2019;s brainstem encephalitis was made. Treatment with plasmapheresis led to a rapid improvement of clinical symptoms. To date, only five similar cases have been reported, but this is the only case in which PRES developed prior to treatment.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>PRES can be a comorbid condition with Bickerstaff&#x2019;s brainstem encephalitis, either preceding or following treatment; caution should be used in patients with either syndrome who exhibit atypical presentations.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Bickerstaff&#x2019;s brainstem encephalitis</kwd>
        <kwd>Guillain-Barre syndrome</kwd>
        <kwd>Miller-Fisher syndrome</kwd>
        <kwd>Posterior reversible encephalopathy syndrome</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>Taipei Veterans General Hospital </institution>
          </funding-source>
          <award-id>V104C-174</award-id>
          <principal-award-recipient>
            <name>
              <surname>Chen</surname>
              <given-names>Shih-Pin</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id>
              <institution>Ministry of Science and Technology, Taiwan</institution>
            </institution-wrap>
          </funding-source>
          <award-id>MOST 104-2314-B-075 -006 -MY3</award-id>
          <principal-award-recipient>
            <name>
              <surname>Chen</surname>
              <given-names>Shih-Pin</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Posterior reversible encephalopathy syndrome (PRES) is characterized by headache, confusion, seizures and visual loss with different triggers and associated conditions, such as acute hypertension, acute kidney injury, eclampsia, sepsis, multi-organ failure, and autoimmune disease [<xref ref-type="bibr" rid="CR1">1</xref>]. The typical neuroimaging findings are reversible vasogenic subcortical edema involving the posterior hemispheres bilaterally. Some case reports have demonstrated the co-occurrence of Guillain-Barre syndrome (GBS) (or its spectral disorder) and PRES [<xref ref-type="bibr" rid="CR2">2</xref>], and intravenous immunoglobulin (IVIG) has been implicated as the cause of PRES in a few cases [<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR7">7</xref>]. The incidence of GBS in the general population is 0.75&#x2013;2 cases per 100,000 [<xref ref-type="bibr" rid="CR8">8</xref>]. The actual incidence of PRES is unknown, but it is estimated to be rare. Therefore, the co-occurrence of both syndromes is unlikely by chance, but rather implicates a common pathogenic basis.</p>
      <p>Here we report a patient in whom PRES was the presenting manifestation of Bickerstaff&#x2019;s brainstem encephalitis (BBE) and discuss the possible pathophysiological mechanisms.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A previously healthy 75-year-old woman complained of severe headache of the bilateral frontal area, accompanied by blurred vision and mild left eyelid ptosis for 3&#xA0;days. She had upper respiratory infection symptoms (cough and sneezing) 2&#xA0;weeks prior to presentation. She developed arterial hypertension (210/100&#xA0;mmHg) at the emergency room (on the 4th day after symptom onset). Neurological examination showed left eyelid ptosis and limited extraocular movements horizontally in the left eye with the pupil sparing (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). There were no sympathetic signs, such as miosis and anhydrosis, nor any long tract signs. A computed tomography-angiography (CTA) excluded cerebral aneurysm or other compressive lesions of the oculomotor nerve. Brain magnetic resonance imaging (MRI) showed T2-weighted hyper-intense signal abnormalities in the occipital lobes bilaterally (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>), appearing iso-intense on diffusion-weighted imaging, with an increase of the apparent diffusion coefficient, consistent with vasogenic edema. These findings were compatible with the diagnosis of PRES. Because of persistent headache and elevated systolic blood pressure, amlodipine and olmesartan were administered. However, the conditions did not improve until nimodipine, 30&#xA0;mg 4 times a day, was added. On the next day, partial ptosis of the right eye developed, followed by bilateral oculomotor and trochlear nerve palsy. Generalized hyporeflexia with bilateral flexor plantar responses was noted. The Romberg test was positive. The finger-nose-finger and heel-knee-shin tests were bilaterally impaired, and an ataxic gait was present. On the 6th day, the patient experienced weakness of the lower limbs bilaterally (MRC: 3/5) and could no longer stand. The partial ptosis of the right eyelid progressed to complete ptosis, and both eyes showed complete external ophthalmoplegia. A test for acetylcholine receptor antibody was negative. Additional laboratory studies, including erythrocyte sedimentation rate, complement factors C3 and C4, antinuclear antibodies, extractable nuclear antigens, antineutrophil cytoplasmic antibody, RNP, anti-SSA, anti-SSB, anti-dsDNA, rheumatic factor, thyroid function, estrogen, FSH, LH, cortisol, ACTH, prolactin, HbA1C, hepatic, and renal function, were within normal limits. Antibodies against gangliosides (including GQ1b) were not checked because of unavailability. Cerebrospinal fluid examination demonstrated albumin-cytological dissociation (protein: 66.6&#xA0;mg/dl, white cell count: 0/&#x3BC;l, glucose: 66&#xA0;mg/dl (serum glucose: 114&#xA0;mg/dl) and albumin: 39.69&#xA0;mg/dl) and an elevated IgG index (0.84). A panel of CSF analysis, including cytology, bacterial culture, fungal culture, and serological titers of viruses including CMV, HSV1, and HSV2, etc. all showed negative results. A nerve conduction study revealed loss of sensory nerve potentials of the bilateral sural, medial, and ulnar nerves. Motor nerve conduction studies showed demyelinating and eventually axon sensorimotor polyneuropathy (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>), which compatible with acquired demyelination neuropathy. Needle electromyography was unrevealing. On the 8th day, the patient had altered consciousness (Glasgow coma scale was E3V4M5) and an extensor plantar response on the left. Hypoxia, uremia, Wernicke&#x2019;s encephalopathy, Addison&#x2019;s disease, hepatic encephalopathy, and alcoholism were excluded on the basis of physical and laboratory findings; however, euvolemic hyponatremia (Na:119&#xA0;mEq/L), compatible with syndrome of inappropriate antidiuretic hormone secretion (SIADH), was noted. Other co-morbidities for hyponatremia or SIADH including malignancy, intracranial infection, hemorrhage, lung disease&#x2026;etc., have been excluded in our patient. A diagnosis of Bickerstaff&#x2019;s brainstem encephalitis with overlapping GBS and SIADH was made. Alternate day plasmapheresis was instituted for five times and the hyponatremia was gradually corrected. Her consciousness level and ophthalmoplegia improved gradually, and she could open her eyes on the 13th day. The patient received an intensive rehabilitation program and showed progressive improvement of neurological deficits. She could walk with cane and showed mild lower limb weakness (MRC: 4/5) on the 17th day. She was discharged on the 21st day with residual mild weakness and dysesthesia of the lower extremities. Two months later, she had completely recovered.<fig id="Fig1"><label>Fig. 1</label><caption><p>Clinical pictures of our patient on the 5<sup>th</sup> day. <bold>a</bold> bilateral ptosis. <bold>b</bold> left eye impaired adduction on right gaze</p></caption><graphic xlink:href="12883_2016_737_Fig1_HTML" id="MO1"/></fig>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Brain MRI of our patent on the 4<sup>th</sup> day. Brain MRI T2-weighted hyper-intense signal abnormalities in the occipital lobes bilaterally</p></caption><graphic xlink:href="12883_2016_737_Fig2_HTML" id="MO2"/></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Motor nerve conduction study. CMAP: compound muscle action potential</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Table 1.</th><th>Distant latency (ms)</th><th>Conduction velocity (m/s)</th><th>CMAP<break/>(mV)</th></tr></thead><tbody><tr><td>L. median n.</td><td>5.9</td><td>26.8</td><td>3.0</td></tr><tr><td>R. median n.</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>L. ulnar n.</td><td>4.6</td><td>43.1</td><td>3.3</td></tr><tr><td>R. ulnar n</td><td>5.0</td><td>44.7</td><td>3.3</td></tr><tr><td>L. peroneal n.</td><td>6.3</td><td>29.9</td><td>2.1</td></tr><tr><td>R. peroneal n.</td><td>5.7</td><td>31.3</td><td>3.6</td></tr><tr><td>L. tibial n.</td><td>5.9</td><td>28.9</td><td>3.6</td></tr><tr><td>R. tibial n.</td><td>6.9</td><td>31.7</td><td>6.5</td></tr></tbody></table></table-wrap>
</p>
    </sec>
    <sec id="Sec3">
      <title>Conclusions</title>
      <p>Our patient presented a clinical and neuroradiological pattern characteristic of PRES preceding a constellation of neurological symptoms, including complete ptosis, external ophthalmoplegia, progressive ataxia, weakness of the lower limbs bilaterally, altered consciousness, and a left extensor plantar reflex, which were consistent with Bickerstaff&#x2019;s brainstem encephalitis with overlapping GBS [<xref ref-type="bibr" rid="CR9">9</xref>]. Although previous reports have suggested that PRES could be the presenting manifestation of GBS [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] and could occur in patients with GBS variants, such as Miller-Fisher syndrome (MFS) or BBE (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>), our case, in contrast to most of the cases, presented with PRES as the first manifestation of BBE with overlapping GBS prior to any intervention. Three previous cases have shown the co-occurrence of MFS or MFS/ BBE-overlap syndrome and non-hypertensive PRES; however, in these cases, IVIG treatment was considered to be the culprit of PRES [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. One recent case demonstrated extensive vasogenic edema in BBE without any intervention; however, whether the vasogenic edema of the deep white matter, brainstem, and cerebellum was attributable to PRES is uncertain [<xref ref-type="bibr" rid="CR13">13</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Four cases of clinical manifestation of MFS/BBE associated with PRES</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Age<break/>(y/o)</th><th rowspan="2">Sex<break/>(M/F)</th><th colspan="4">Initial GBS (MFS/BBE) symptoms and signs</th><th rowspan="2">Initial PRES symptoms</th><th rowspan="2">HTN</th><th rowspan="2">MRI findings</th><th rowspan="2">antecedent infection</th><th rowspan="2">IVIG intervention</th><th rowspan="2"/></tr><tr><th>OAA</th><th>Mental disturbance</th><th>Weakness</th><th>Plantar reflex</th></tr></thead><tbody><tr><td>53</td><td>M</td><td>+</td><td>NA</td><td>&#x2212;</td><td>NA</td><td>Headache<break/>(4&#xA0;days after IVIG)</td><td>200/130&#xA0;mmHg (4&#xA0;days after IVIG)</td><td>Bilateral O-P-T<break/>Cerebellum<break/>Basal ganglion<break/>Brainstem</td><td>Yes</td><td>Yes</td><td>[<xref ref-type="bibr" rid="CR4">4</xref>]</td></tr><tr><td>29</td><td>F</td><td>+</td><td>+<break/>(48&#xA0;h after IVIG)</td><td>+</td><td>NA</td><td>Altered mental status<break/>(48&#xA0;h after IVIG)</td><td>&#x2212;</td><td>Brain stem,<break/>Bilateral F-P-O</td><td>No</td><td>Yes</td><td>[<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td>54</td><td>F</td><td>+</td><td>+<break/>(24&#x2013;48&#xA0;h after IVIG)</td><td>&#x2212;</td><td>bilateral flexor</td><td>Headache<break/>Seizure<break/>(24&#x2013;48&#xA0;h after IVIG)</td><td>&#x2212;</td><td>Bilaterally P-O</td><td>No</td><td>Yes</td><td>[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td>75<break/>(our patient)</td><td>F</td><td>+</td><td>+<break/>(day 8)</td><td>+<break/>(day 6)</td><td>left extensor</td><td>Headache<break/>Blurred vision</td><td>210/100&#xA0;mmHg (day 4)</td><td>Bilateral O</td><td>Yes<break/>URI: 14&#xA0;days before symptoms onset</td><td>No</td><td/></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <italic>MFS</italic> Miller-Fisher syndrome, <italic>BEE</italic> Bickerstaff brainstem encephalitis, <italic>PRES</italic> posterior reversible encephalopathy syndrome, <italic>OAA</italic> ophthalmoplegia, ataxia, and areflexia, <italic>HTN</italic> hypertension, <italic>URI</italic> upper respiratory infection, <italic>O</italic> occipital lobe, <italic>P</italic> parietal lobe, <italic>T</italic> temporal lobe, <italic>F</italic> frontal lobe</p></table-wrap-foot></table-wrap>
</p>
      <p>The causal relationship between PRES and BBE is uncertain, but presumably is similar to that between PRES and GBS. There are some possible mechanisms that might explain the association between GBS and PRES [<xref ref-type="bibr" rid="CR14">14</xref>]. One of them is dysautonomia. Dysautonomia is reported in 52&#xA0;% to two thirds of all GBS patients [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. It can lead to a marked blood pressure surge with overwhelmed cerebrovascular auto-regulation, causing increased brain-blood capillary permeability, impaired blood-brain barrier, and eventually the development of PRES [<xref ref-type="bibr" rid="CR17">17</xref>]. The other one is the increased level of circulating cytokines and chemokines. Pro&#x2010;inflammatory cytokines, such as interferon&#x2010;&#x3B3; and tumor necrosis factor&#x2010;&#x3B1;, released by T lymphocytes play a critical role in the pathogenesis of inflammatory demyelination of the peripheral nervous system [<xref ref-type="bibr" rid="CR18">18</xref>]. Increased levels of chemokines, such as CCL2-CCR2, CCL5-CCR5, and CXCL10-CXCR3, have been found in GBS and experimental autoimmune neuritis in humans and animal studies, respectively [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. These pro-inflammatory mediators may also contribute to the pathogenesis of PRES by changing capillary permeability and by enhancing the disruption of the blood-brain barrier [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
      <p>The etiology of SIADH in our patient was uncertain, but we considered it to be comorbidity attributed to her Bickerstaff&#x2019;s brainstem encephalitis. SIADH has been reported in 7&#x2013;48&#xA0;% of patients with GBS [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The mechanism of which was hypothesized to be downward osmotic resetting and enhanced renal tubular sensitivity to antidiuretic hormone [<xref ref-type="bibr" rid="CR24">24</xref>&#x2013;<xref ref-type="bibr" rid="CR26">26</xref>]. Of note, SIADH has been associated with poor outcome in GBS as bulbar weakness and such as the need of ventilator support or longer hospitalization period [<xref ref-type="bibr" rid="CR22">22</xref>]. Fortunately, our patient did not run into this devastating disease cause.</p>
      <p>To conclude, PRES could be the initial presentation of BBE, either due to an immunological reaction against both the central and peripheral nervous systems or as a result of acute hypertension caused by autonomic dysfunction. Although the accurate rate of co-occurrence of these two syndromes remains to be explored in large-scale prospective studies, a comorbid PRES should be considered in patients with initial signs of GBS or its spectral disorders, especially in those with a blood pressure surge or visual field defect.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>BBE</term>
          <def>
            <p>Bickerstaff brainstem encephalitis</p>
          </def>
        </def-item>
        <def-item>
          <term>GBS</term>
          <def>
            <p>Guillain-Barre syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>IVIG</term>
          <def>
            <p>Intravenous immunoglobulin</p>
          </def>
        </def-item>
        <def-item>
          <term>MFS</term>
          <def>
            <p>Miller-Fisher syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>PRES</term>
          <def>
            <p>Posterior reversible encephalopathy syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>SIADH</term>
          <def>
            <p>Syndrome of inappropriate antidiuretic hormone secretion</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Acknowledgements</title>
      <p>Not applicable.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>This work was supported by Taipei Veterans General Hospital (V104C-174 to S.P.C) and the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-075 -006 -MY3 to S.P.C). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The dataset supporting the conclusions of this article is included within the article.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>PRC acquired and interpreted the data and drafted the manuscript; SPC is responsible for the study concept and design, and critically revised the manuscript for important intellectual content. Both authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the patient for review of her records for publication. The patient consented for the publication of the report and any accompanying images. A copy of the written consent is available for review.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>The authors declare that ethics approval was not required for this case report.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hobson</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Craven</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Blank</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness</article-title>
          <source>Perit Dial Int</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>590</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="doi">10.3747/pdi.2012.00152</pub-id>
          <pub-id pub-id-type="pmid">23212858</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Berkowitz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome in Guillain-Barre syndrome</article-title>
          <source>J Clin Neurosci</source>
          <year>2015</year>
          <volume>22</volume>
          <fpage>914</fpage>
          <lpage>916</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jocn.2014.11.004</pub-id>
          <pub-id pub-id-type="pmid">25800144</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doss-Esper</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Singhal</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>GV</given-names>
            </name>
          </person-group>
          <article-title>Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome</article-title>
          <source>J Neuroimaging</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>188</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">15746232</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakajima</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with miller-fisher syndrome</article-title>
          <source>Eur Neurol</source>
          <year>2005</year>
          <volume>54</volume>
          <fpage>58</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1159/000087720</pub-id>
          <pub-id pub-id-type="pmid">16118497</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stetefeld</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Burghaus</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome and stroke after intravenous immunoglobulin treatment in Miller-Fisher syndrome/Bickerstaff brain stem encephalitis overlap syndrome</article-title>
          <source>J Stroke Cerebrovasc Dis</source>
          <year>2014</year>
          <volume>23</volume>
          <fpage>e423</fpage>
          <lpage>e425</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2014.05.034</pub-id>
          <pub-id pub-id-type="pmid">25149206</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koichihara</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hamano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barre syndrome</article-title>
          <source>Pediatr Neurol</source>
          <year>2008</year>
          <volume>39</volume>
          <fpage>123</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2008.04.005</pub-id>
          <pub-id pub-id-type="pmid">18639758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Incecik</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Herguner</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Altunbasak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yildizdas</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barre syndrome</article-title>
          <source>J Pediatr Neurosci</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>138</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="pmid">22408666</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ropper</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>The Guillain-Barre syndrome</article-title>
          <source>N Engl J Med</source>
          <year>1992</year>
          <volume>326</volume>
          <fpage>1130</fpage>
          <lpage>1136</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199204233261706</pub-id>
          <pub-id pub-id-type="pmid">1552914</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wakerley</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Uncini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yuki</surname>
              <given-names>N</given-names>
            </name>
            <collab>GBS Classification Group</collab>
            <collab>GBS Classification Group</collab>
          </person-group>
          <article-title>Guillain-Barr&#xE9; and Miller Fisher syndromes&#x2014;new diagnostic classification</article-title>
          <source>Nat Rev Neurol</source>
          <year>2014</year>
          <volume>10</volume>
          <fpage>537</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="doi">10.1038/nrneurol.2014.138</pub-id>
          <pub-id pub-id-type="pmid">25072194</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banakar</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Pujar</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Bhargava</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khichar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Guillain-Barre syndrome with posterior reversible encephalopathy syndrome</article-title>
          <source>J Neurosci Rural Pract</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>63</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.4103/0976-3147.127877</pub-id>
          <pub-id pub-id-type="pmid">24741255</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nabi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rajput</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Badshah</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain-Barre&#x2019; syndrome (GBS)</article-title>
          <source>BMJ Case Rep</source>
          <year>2016</year>
          <volume>3</volume>
          <fpage>2016</fpage>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Salata</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Borges</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Marchiori</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome following immunoglobulin therapy in a patient with Miller-Fisher syndrome</article-title>
          <source>Radiol Bras</source>
          <year>2016</year>
          <volume>49</volume>
          <fpage>58</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="doi">10.1590/0100-3984.2015.0129</pub-id>
          <pub-id pub-id-type="pmid">26929465</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nerrant</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fourcade</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Coulette</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lechiche</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Thouvenot</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Teaching NeuroImages: Extensive vasogenic edema in Bickerstaff brainstem encephalitis</article-title>
          <source>Neurology</source>
          <year>2016</year>
          <volume>86</volume>
          <fpage>e38</fpage>
          <lpage>e39</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000002309</pub-id>
          <pub-id pub-id-type="pmid">26810429</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rigamonti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Scaccabarozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lauria</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barre syndrome: case report and review of the literature</article-title>
          <source>J Peripher Nerv Syst</source>
          <year>2012</year>
          <volume>17</volume>
          <fpage>356</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1529-8027.2012.00416.x</pub-id>
          <pub-id pub-id-type="pmid">22971098</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vassallo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Plant</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Bladder dysfunction and hypertension in children with Guillain-Barre syndrome</article-title>
          <source>Pediatr Nephrol</source>
          <year>2014</year>
          <volume>29</volume>
          <fpage>1637</fpage>
          <lpage>1641</lpage>
          <pub-id pub-id-type="doi">10.1007/s00467-014-2799-2</pub-id>
          <pub-id pub-id-type="pmid">24651942</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burakgazi</surname>
              <given-names>AZ</given-names>
            </name>
            <name>
              <surname>Almahameed</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cardiac Involvement in Peripheral Neuropathies</article-title>
          <source>J Clin Neuromuscul Dis</source>
          <year>2016</year>
          <volume>17</volume>
          <fpage>120</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="doi">10.1097/CND.0000000000000106</pub-id>
          <pub-id pub-id-type="pmid">26905912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Feske</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy</article-title>
          <source>Radiology</source>
          <year>2000</year>
          <volume>217</volume>
          <fpage>371</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="doi">10.1148/radiology.217.2.r00nv44371</pub-id>
          <pub-id pub-id-type="pmid">11058630</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="other">Mathey EK, Park SB, Hughes RA, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. 2015;86:973&#x2013;85.</mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luster</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Chemokines&#x2014;chemotactic cytokines that mediate inflammation</article-title>
          <source>N Engl J Med</source>
          <year>1998</year>
          <volume>338</volume>
          <fpage>436</fpage>
          <lpage>445</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199802123380706</pub-id>
          <pub-id pub-id-type="pmid">9459648</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ubogu</surname>
              <given-names>EE</given-names>
            </name>
          </person-group>
          <article-title>The role of chemokines in Guillain-Barre syndrome</article-title>
          <source>Muscle Nerve</source>
          <year>2013</year>
          <volume>48</volume>
          <fpage>320</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="doi">10.1002/mus.23829</pub-id>
          <pub-id pub-id-type="pmid">23447114</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kieseier</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Tani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mahad</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10</article-title>
          <source>Brain</source>
          <year>2002</year>
          <volume>125</volume>
          <fpage>823</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awf070</pub-id>
          <pub-id pub-id-type="pmid">11912115</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saifudheen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jose</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gafoor</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Musthafa</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Guillain-Barre syndrome and SIADH</article-title>
          <source>Neurology</source>
          <year>2011</year>
          <volume>76</volume>
          <fpage>701</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0b013e31820d8b40</pub-id>
          <pub-id pub-id-type="pmid">21339497</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonz&#xE1;lez-Su&#xE1;rez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sanz-Gallego</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez De Rivera</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Arpa</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Guillain-Barr&#xE9; syndrome: natural history and prognostic factors: a retrospective review of 106 cases</article-title>
          <source>BMC Neurol</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>95</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2377-13-95</pub-id>
          <pub-id pub-id-type="pmid">23876199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Posner</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Ertel</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Kossmann</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Scheinberg</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Hyponatremia in acute polyneuropathy: four cases with the syndrome of inappropriate secretion of antidiuretic hormone</article-title>
          <source>Arch Neurol</source>
          <year>1967</year>
          <volume>17</volume>
          <fpage>530</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.1967.00470290084011</pub-id>
          <pub-id pub-id-type="pmid">4293349</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Penney</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Walters</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Resetting of osmoreceptor response as cause of hyponatraemia in acute idiopathic polyneuritis</article-title>
          <source>BMJ</source>
          <year>1979</year>
          <volume>2</volume>
          <fpage>1474</fpage>
          <lpage>1476</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.2.6203.1474</pub-id>
          <pub-id pub-id-type="pmid">526815</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooke</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Latif</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Huch</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Wall</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Inappropriate antidiuresis and hyponatremia with suppressible vasopressin in Guillain-Barr&#xE9; syndrome</article-title>
          <source>Am J Nephrol</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>71</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1159/000013309</pub-id>
          <pub-id pub-id-type="pmid">9481444</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
